Therapeutics Company Announce FDA Acceptance For New Galactosemia Treatment

Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia: A Revolution in Healthcare.

Disclaimer: All information presented is accurate and up-to-date as of the time of writing.

In a significant development for the healthcare sector and investors worldwide, Applied Therapeutics Inc. (NASDAQ:APLT), a clinical-stage biopharmaceutical company, has announced the Food and Drug Administration's acceptance and priority review of their New Drug A…